• Bruno Messina Coimbra, Mary Yeh, Ana Teresa D'Elia, Mariana Rangel Maciel, Carolina Muniz Carvalho, Ana Carolina Milani, Adriana Mozzambani, Mario Juruena, Sintia Iole Belangero, Andrea Parolin Jackowski, Dalva Poyares, Andrea Feijo Mello, and Marcelo Feijo Mello.
• Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil.
• JMIR Res Protoc. 2020 Nov 18; 9 (11): e19162.

BackgroundPosttraumatic stress disorder (PTSD) is a prevalent, chronic, and severe disorder related to traumatic events. Women are disproportionately affected by PTSD than men and are more at risk in the occurrence of sexual assault victimization. Estimates suggest that 50% of women develop PTSD following sexual assault and successful clinical management can be challenging. Growing evidence has implicated neural, immune, and endocrine alterations underpinning PTSD, but only few studies have assessed the evolution of acute PTSD in women.ObjectiveThis study aims to measure whether the onset of PTSD is associated with accelerated aging in women following sexual assault. We hypothesize that the increase of allostatic load caused by PTSD leads to neuroprogression. We will implement a randomized clinical trial to compare responses to treatment with either interpersonal psychotherapy adapted for PTSD (IPT-PTSD) or the selective serotonin reuptake inhibitor sertraline.MethodsWe will include women between 18 and 45 years of age, who experienced sexual assault from 1 to 6 months before the initial evaluation, and present with a Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) diagnosis of PTSD. Baseline evaluation will comprise clinical and psychometric assessments, structural and functional magnetic resonance imaging, neuropsychological testing, polysomnography, evaluation of immune and endocrine parameters, and genetic analyses. Age-matched female healthy controls will be included and subjected to the same evaluation. Patients will be randomized for treatment in 1 of the 2 arms of the study for 14 weeks; follow-up will continue until 1 year after inclusion via treatment as usual. The researchers will collect clinical and laboratory data during periodic clinical assessments up to 1-year follow-up.ResultsData collection started in early 2016 and will be completed by the end of the first semester of 2020. Analyses will be performed soon afterward, followed by the elaboration of several articles. Articles will be submitted in early 2021. This research project has obtained a grant from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2014/12559-5).ConclusionsWe expect to provide insight into the consequences of recent sexual assault exposure in women by investigating the degree of neuroprogression developing from an early stage of PTSD. We also expect to provide important evidence on the efficacy of a non-exposure psychotherapy (IPT-PTSD) to mitigate PTSD symptoms in recently sexually assaulted women. Further, we aim to obtain evidence on how treatment outcomes are associated with neuroprogression measures.Trial RegistrationBrazilian Clinical Trials Registry RBR-3z474z; http://www.ensaiosclinicos.gov.br/rg/RBR-3z474z/.International Registered Report Identifier (Irrid)DERR1-10.2196/19162.©Bruno Messina Coimbra, Mary Yeh, Ana Teresa D'Elia, Mariana Rangel Maciel, Carolina Muniz Carvalho, Ana Carolina Milani, Adriana Mozzambani, Mario Juruena, Sintia Iole Belangero, Andrea Parolin Jackowski, Dalva Poyares, Andrea Feijo Mello, Marcelo Feijo Mello. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 18.11.2020.

7 keywords...

hide…